Prelude Capital Management, LLC Pacira Bio Sciences, Inc. Transaction History

Prelude Capital Management, LLC

$934 Million
Q2 2025

A detailed history of Prelude Capital Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 24,235 shares of PCRX stock, worth $557,889. This represents 0.06% of its overall portfolio holdings.

Number of Shares

24,235

Previous 24,339 0.43%

Holding current value

$557,889

Previous $604,000 4.14%

% of portfolio

0.06%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$22.91 - $27.14 $2,382 - $2,822	-104 Reduced 0.43%	24,235 $579,000
Q1 2025 May 15, 2025	BUY	$18.33 - $27.25 $88,057 - $130,909	4,804 Added 24.59%	24,339 $604,000
Q4 2024 Feb 14, 2025	SELL	$15.3 - $20.33 $36,720 - $48,791	-2,400 Reduced 10.94%	19,535 $368,000
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $29,460 - $71,662	2,518 Added 12.97%	21,935 $330,000
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $124,746 - $154,146	4,892 Added 33.68%	19,417 $555,000
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $217,195 - $278,198	7,841 Added 117.31%	14,525 $424,000
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $175,922 - $229,328	6,684 New	6,684 $225,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $252,478 - $332,025	6,990 New	6,990 $280,000
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $128,261 - $203,365	2,491 Added 33.91%	9,837 $573,000
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $268,994 - $342,751	-4,481 Reduced 37.89%	7,346 $561,000
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $567,341 - $735,757	11,827 New	11,827 $712,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $802,780 - $973,161	-15,447 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $94,186 - $160,453	3,058 Added 24.68%	15,447 $811,000
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $195,250 - $348,562	6,875 Added 124.68%	12,389 $415,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $114,739 - $147,982	-3,160 Reduced 36.43%	5,514 $250,000
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $308,565 - $389,298	-8,653 Reduced 49.94%	8,674 $330,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $626,114 - $821,294	17,121 Added 8311.17%	17,327 $754,000
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $7,512 - $8,687	206 New	206 $8,000

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

51M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.05B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Pacira Bio Sciences, Inc. Transaction History